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Background: The Gene Ontology (GO) (http://www.geneontology.org/) contains a set of terms for describing
the activity and actions of gene products across all kingdoms of life. Each of these activities is executed in a
location within a cell or in the vicinity of a cell. In order to capture this context, the GO includes a sub-ontology
called the Cellular Component (CC) ontology (GO-CCO). The primary use of this ontology is for GO annotation,
but it has also been used for phenotype annotation, and for the annotation of images. Another ontology with
similar scope to the GO-CCO is the Subcellular Anatomy Ontology (SAO), part of the Neuroscience Information
Framework Standard (NIFSTD) suite of ontologies. The SAO also covers cell components, but in the domain
of neuroscience.
Description: Recently, the GO-CCO was enriched in content and links to the Biological Process and Molecular
Function branches of GO as well as to other ontologies. This was achieved in several ways. We carried out an
amalgamation of SAO terms with GO-CCO ones; as a result, nearly 100 new neuroscience-related terms were
added to the GO. The GO-CCO also contains relationships to GO Biological Process and Molecular Function
terms, as well as connecting to external ontologies such as the Cell Ontology (CL). Terms representing protein
complexes in the Protein Ontology (PRO) reference GO-CCO terms for their species-generic counterparts.
GO-CCO terms can also be used to search a variety of databases.
Conclusions: In this publication we provide an overview of the GO-CCO, its overall design, and some recent
extensions that make use of additional spatial information. One of the most recent developments of the GO-CCO
was the merging in of the SAO, resulting in a single unified ontology designed to serve the needs of GO
annotators as well as the specific needs of the neuroscience community.
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The Gene Ontology (GO) [1,2] contains a set of terms
for describing the activity and actions of gene products
across all kingdoms of life. Each of these activities is ex-
ecuted in a cellular location or a location outside in the
vicinity of a cell. In order to capture this context, the GO
includes, since its inception, a sub-ontology called the Cel-
lular Component Ontology (GO-CCO). GO-CCO terms
describe parts of cells and structures associated with cells
throughout the taxonomy range. The primary use of this
ontology is for GO annotation, but it has also been used
for phenotype annotation. Another ontology with a similar
scope to the GO-CCO is the Subcellular Anatomy Ontol-
ogy (SAO) [3], part of the Neuroscience Information
Framework Standard (NIFSTD) [4] suite of ontologies.
The SAO covers cellular components in the domain of
neuroscience and was designed as a model for describ-
ing relationships among subcellular structures that
would be encountered in an electron micrograph, for
example a neuropil. In the nervous system, there are
numerous examples of named subcellular structures
that are composed of parts of multiple cell types, e.g.,
synapses, the Node of Ranvier, the glia limitans. SAO
thus has a richer set of spatial relationships than the
GO, modeled in part after the Foundational Model of
Anatomy (FMA) [5].
At the time the SAO was constructed, circa 2005–2006,
tools for import and reuse of existing ontologies were lim-
ited; in addition the SAO was composed in OWL (Web
Ontology Language), while the GO-CCO was in OBO
(Open Biomedical Ontologies) format. At this time, the se-
mantics of OBO format were not yet aligned with those of
OWL. Thus, the SAO had developed an independent set
of cell component terms, with a heavy focus on those en-
countered in the nervous system. More recently, with the
advent of a more detailed specification of OBO format
(which clarifies the semantics of OBO format as a subset
of OWL2) and the development of OBO/OWL con-
verters, the native format of an ontology is less relevant.
This has allowed us to work together on the same ontol-
ogy by incorporating the SAO into the GO-CCO.
The SAO was used primarily within prototype segmenta-
tion and annotation tools developed for electron tomog-
raphy data [6] to enhance search within the NIF across
federated data [4] and, as described below, to annotate data
derived from imaging and the literature on phenotypes as-
sociated with neurodegenerative disease [7]. To ensure that
these annotations are not lost, NIF maintains a mapping
between SAO and GO-CCO within a bridge file (for details
on the use of bridge files in NIFSTD, see [8]).
In this paper, we describe an overview of the GO-CCO,
a description of the amalgamation of the GO-CCO with
the SAO, followed by a sketch of how the GO-CCO fits in
with other ontologies. The last part of the paper describesapplications and uses of the GO-CCO. Our aim is to pro-
vide a single unified cellular component ontology that can
serve the needs of a diverse scientific community. The bio-
medical and bioinformatics communities may also benefit
from the links between the GO-CCO and other ontologies.
The URL for the Gene Ontology (GO) is http://www.
geneontology.org/. GO files are publicly available for download
at http://geneontology.org/GO.downloads.ontology.shtml.
Overview of the Cellular Component Ontology
The Cellular Component Ontology describes subcellular
structures and macromolecular complexes. GO-CCO
terms may thus be used to annotate cellular locations of
gene products. Examples of cellular components include
‘nuclear inner membrane’ (Figure 1) and the ‘ubiquitin lig-
ase complex’, with several subtypes of this complex repre-
sented as descendants. The GO-CCO is not taxonomically
restricted, and includes terms for both core components
found across all domains of life (for example, the species-
generic ‘chromosome’) and components specific to par-
ticular lineages (for example, ‘Nebenkern’, a mitochondrial
formation found in insects, and ‘thylakoid’, a compartment
inside chloroplasts and cyanobacteria).
The two core relationship types used in the GO-CCO are
‘is_a’ and ‘part_of ’. The ‘is_a’ relation (also known as
“SubClassOf”) represents the relationship between a more
generic term and a specialized term (for example, between
‘membrane’ and ‘plasma membrane’), whereas the ‘part_of ’
relationship describes how sub-structures are assembled
into larger structures (for example, between ‘nucleolus’ and
‘nucleus’) [9].
Generally, experimental results or computational predic-
tions support statements that a gene product is located in
or is a subcomponent of a particular cellular component.
The GO-CCO includes multi-subunit enzymes and other
protein complexes, but not individual proteins or nucleic
acids. (Terms describing protein complexes are further
discussed below.) Whilst the GO-CCO includes cell struc-
tures, it excludes cell types, which are instead represented
in the Cell Ontology (CL) [10] or the plant cell branch
of the Plant Ontology (PO) [11]. The GO-CCO also ex-
cludes multicellular anatomical terms, with such struc-
tures being described by either species-specific ontologies
(e.g., Zebrafish anatomy ontology [12], Mouse gross anat-
omy ontology [13]) or taxonomically broad anatomical on-
tologies (e.g., Uberon [14], PO).
The 2013-06-18 release of the GO contains 3332 CC
ontology terms. Approximately half of these terms repre-
sent protein complexes, with the other half representing
larger units.
Amalgamation with SAO
The SAO was incorporated into the Neuroscience Infor-
mation Framework standard ontologies when they were
Figure 1 Diagram and ontology placement of 'nuclear inner membrane'. (A) Diagram of human cell nucleus, including the nuclear inner
membrane. (Taken from Wikimedia commons, http://upload.wikimedia.org/wikipedia/commons/thumb/3/38/Diagram_human_cell_nucleus.svg/
2000px-Diagram_human_cell_nucleus.svg.png). (B) Placement of the Gene Ontology term GO:0005637 'nuclear inner membrane', drawn using
the ontology editing tool OBO-Edit (see ‘Methods’). Due to space limitations, not all ancestor and descendant terms are shown. Is_a links are
indicated by "I"; part_of links are indicated by "P" (see main text for explanation).
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[16] was charged with providing a semantic framework
for describing and searching neuroscience data.
NIFSTD was built from community ontologies when
possible, but as noted above, working with community
ontologies was often a challenge when the project
began. Over the course of the project, NIF gradually re-
placed its custom ontologies with more general com-
munity ontologies when they became available, both to
benefit from the continued enrichment of these ontol-
ogies by the life sciences community and to ensure that
annotations in the NIF would be compatible with the
larger life sciences community. In this case, a reconcili-
ation of the NIF and the GO-CCO was required.
Through this reconciliation, not only would NIF’s data
federation and search benefit from the on-going devel-
opment and extensive use of the GO for annotations,
but the community ontologies would become enriched
with the neuroscience-specific content developed by
NIF. The SAO-GO-CCO integration is an example of
this type of harmonization.
We started from a list of about 400 terms from the
NIF Subcellular Anatomy Ontology (SAO) representing
sub-cellular locations that required integration into the
GO-CCO. GO editors carefully examined the list and
considered each term as appropriate. The following cat-
egories were identified:
1) Terms that were already in the GO;
2) Terms that needed to be added to the GO;
3) Terms that were out of scope for the GO.Terms that were already in the GO were:
- high-level GO-CCO terms that were included in the
SAO to provide some structure (e.g. ‘plasma
membrane’);
- recent additions to the GO that had not yet been
documented in SAO; in these cases, the NIFSTD IDs have
been included in the GO as database cross-references;
- present in the GO under a different primary name
than used by the SAO/NIF; where appropriate, the
missing SAO names have been added to the GO as
synonyms, along with their NIFSTD IDs.
SAO terms that needed to be added to the GO were cre-
ated, and their NIFSTD IDs recorded as database cross-
references. Definitions for the SAO terms were taken from
the SAO where available, edited if necessary, or written by
GO editors based on the literature or after consultation
with SAO editors. 97 new terms were added to the GO
(e.g. ‘dendritic tree’ (Figure 2), ‘ribbon synapse’); their full
list is shown in Table 1.
The newly added GO-CCO terms (integrated from
SAO) include cytoplasmic inclusions such as ‘Lewy body’
and subtypes, cell-type specific variants of structures such
as ‘CA3 hippocampus pyramidal cell dendrite’ and ter-
minal boutons such as ‘C bouton’ (Figure 3). Very specific
terms such as ‘CA3 hippocampus pyramidal cell dendrite’
have been included because they represent instances with
peculiarities that influence their biological role, e.g. be-
cause they convey particular electrical properties. The full
list of newly added terms is available in Table 1.
Figure 2 Image and ontology placement of ‘dendritic tree’. (A) Dendritic tree from a Purkinje neuron from mouse cerebellum injected with
Lucifer Yellow and imaged using confocal microscopy. (Taken from the Cell Centered Database (CCDB), http://ccdb.ucsd.edu/sand/main?
mpid=3&event=displayRecon). (B) Placement of the newly added Gene Ontology term GO:0097447 'dendritic tree', drawn using the ontology
editing tool OBO-Edit (see ‘Methods’). Due to space limitations, not all ancestor and descendant terms are shown. Is_a links are indicated by "I";
part_of links are indicated by "P" (see main text for explanation). Has_part links are also discussed in the main text.
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terms, and were therefore out of scope for the GO. In-
stead, they were suggested as additions to ontologies such
as Uberon (e.g. ‘axon bundle’, defined as ‘Group of myelin-
ated or unmyelinated axons that group together.’).
Some recent extensions that make use of additional
spatial information
Has_part
In addition to is_a and part_of within the GO-CCO, the
GO also makes use of additional relationship types, both
within the GO-CCO and connecting the GO-CCO to
other ontologies.
Recently the has_part (BFO:0000051) relation was added
to the GO-CCO [17] to represent the composition of
components with respect to their sub-components. These
relationships add value beyond the reciprocal part_of rela-
tionships because they add a dependency of a structure to
always have a certain sub-part. While it is true to say that
every nucleus is part of a cell at every point during the ex-
istence of that nucleus, it is not true that every cell has a
nucleus (exceptions including bacterial cells and mamma-
lian erythrocytes) – thus the GO-CCO includes a part_of
link between nucleus and cell, but no reciprocal has_part
link. Similarly, there is a has_part link between ‘trans
splicesomal complex’ and ‘U2 snRNP’, but no reciprocal
part_of link. U2 snRNPs are not always a part of a trans
splicesomal complex, but every trans splicesomal complex
has a U2 snPNP part.
Connecting cell components to cell types
To record the connections between terms in the GO-
CCO and cell types in the cell type ontology, the GOmaintains an additional supplementary bridging ontology
called x-cell-parts.owl [18] that contains statements such
as ‘astrocyte projection’ part_of some ‘astrocyte’. The
former term belongs to the GO and the latter to the Cell
Ontology (CL) [10,19]. In addition, the Cell Ontology in-
cludes links from cell types such as ‘nucleate erythrocyte’
to GO-CCO terms such as ‘nucleus’. These can be found
in the full version of the Cell Ontology [20].
Connecting biological processes and molecular functions to
cell components
Logical definitions (equivalence axioms) are being
added to the GO that link the Biological Process (BP)
and Molecular Function (MF) branches of the ontology
to the GO-CCO [21]. These additional axioms are
available in an extended version of the GO called go-
plus [22], and allow for fuller reasoning over GO as
well as for automation of new term creation using the
GO TermGenie system [manuscript in preparation].
This work is ongoing, and axioms are being added
using relationships such as results_in_assembly_of,
results_in_disassembly_of, occurs_in, has_start_location,
capable_of. Some examples of such relationships in
OWL are shown below. For illustrative purposes we
use a variant of OWL Manchester Syntax where we in-
clude labels in with the identifiers to enhance
readability.
Class: ‘GO:0000045 ! autophagic vacuole assembly’
EquivalentTo:
‘GO:0022607 ! cellular component assembly’ and
results_in_assembly_of some ‘GO:0005776 !
autophagic vacuole’
Table 1 Terms added to GO-CCO from SAO
GO:0043220 Schmidt-Lanterman incisure
GO:0044224 juxtaparanode region of axon
GO:0044225 apical pole of neuron
GO:0044226 basal pole of neuron
GO:0044280 subplasmalemmal coating
GO:0044284 mitochondrial crista junction
GO:0044285 bridge contact site
GO:0044286 peg and socket contact
GO:0044288 puncta adhaerentia
GO:0044289 contact site
GO:0044290 mitochondrial intracristal space
GO:0044291 cell-cell contact zone
GO:0044292 dendrite terminus
GO:0044293 dendriole
GO:0044294 dendritic growth cone
GO:0044295 axonal growth cone
GO:0044296 dendritic tuft
GO:0044299 C-fiber
GO:0044300 cerebellar mossy fiber
GO:0044301 climbing fiber
GO:0044302 dentate gyrus mossy fiber
GO:0044303 axon collateral
GO:0044304 main axon








GO:0097409 glial cytoplasmic inclusion
GO:0097412 hyaline inclusion
GO:0097413 Lewy body
GO:0097414 classical Lewy body
GO:0097415 cortical Lewy body






GO:0097423 mitochondrion-associated adherens complex
GO:0097424 nucleolus-associated heterochromatin
GO:0097425 smooth endoplasmic reticulum part






GO:0097442 CA3 pyramidal cell dendrite
GO:0097443 sorting endosome
GO:0097444 spine apparatus





GO:0097451 glial limiting end-foot
GO:0097453 mesaxon
GO:0097454 Schwann cell microvillus
GO:0097455 spiny bracelet of Nageotte
GO:0097456 terminal loop







GO:0097471 mossy fiber rosette
GO:1901588 dendritic microtubule










GO:1990016 neck portion of tanycyte
GO:1990017 somatic portion of tanycyte
GO:1990018 tail portion of tanycyte
GO:1990024 C bouton
GO:1990025 F bouton
GO:1990026 hippocampal mossy fiber expansion
GO:1990027 S bouton
GO:1990030 pericellular basket
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Table 1 Terms added to GO-CCO from SAO (Continued)
GO:1990031 pinceau fiber
GO:1990032 parallel fiber
GO:1990033 dendritic branch point
GO:1990037 Lewy body core
GO:1990038 Lewy body corona
GO:1990039 hypolemmal cisterna
GO:1990040 sub-surface cisterna
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EquivalentTo:
‘GO:0022411 ! cellular component disassembly’ and
results_in_disassembly_of some ‘GO:0005681 !
spliceosomal complex’
Class: ‘GO:0006264 ! mitochondrial DNA replication’
EquivalentTo:
‘GO:0006260 ! DNA replication’ and
‘BFO:0000062 ! occurs_in’ some ‘GO:0005739 !
mitochondrion’
Class: ‘GO:0006888 ! ER toGolgi vesicle-mediated transport’
EquivalentTo:
‘GO:0016192 ! vesicle-mediated transport’and
has_target_end_location some ‘GO:0005794 !
Golgi apparatus’and has_target_start_location some
‘GO:0005783 ! endoplasmic reticulum’Figure 3 Representation of 'synapse part' in the Gene Ontology. Child
ontology editing tool OBO-Edit (see ‘Methods’). Terms underlined in green
limitations, not all ancestor and descendant terms are shown. Is_a links areTerms that describe protein complexes and integration
with the Protein Ontology
Of the current 3332 terms in the GO-CCO, 1622 terms
are descendants of GO:0032991 macromolecular complex;
most of these (1510) are descendants of GO:0043234 pro-
tein complex.
Like the rest of GO, protein complexes in the GO-CCO
should be applicable to more than one species. This can
be difficult to achieve when a complex has been character-
ized in a single species, or homology among species is un-
clear. In these cases our aim is to make the term as
generic as possible. A protein complex from a particular
species is often described in the GO-CCO textual
definition, but the scope of that term is not limited to that
species. Other resources can use these generic protein-
complex terms to classify more specific entities. For
example, the Protein Ontology (PRO) [23] makes species-
specific protein complex subclasses of the generic GO
protein complexes.
An example of a protein complex, the mouse-specific
form of eukaryotic translation initiation factor 2
complex 1, is represented in PRO using the ID
PR:000026828 (Figure 4). Each species-specific transla-
tion initiation factor complex is composed of specific
protein entities, which can be any combination
of isoforms, processed forms, or post-translationally
modified forms. In this example, the mouse complex is
shown. The human complex would be defined using
human proteins and would be restricted to the humanren of the GO term. GO:0044456 'synapse part' are shown using the
were added as part of the SAO amalgamation. Due to space
indicated by "I" (see main text for explanation).
Figure 4 Protein ontology report for entry PR:000026828. Ontology information for the Protein Ontology term 'eukaryotic translation
initiation factor 2 complex 1 (mouse)', showing parent GO term and has_part links to other PR terms [25].
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with an is_a relationship to the generic GO complex.
At present, there are almost 500 protein complex terms
in PRO [24].
GO-CCO protein complexes are defined by some com-
bination of their biological function, their subunit com-
position in one or more species, and their location within
the cell. Protein complexes in the GO range from simple
dimeric complexes, for example ‘TAP complex’, to com-
plexes having many subunits, for example ‘proteasome
complex’. Homodimeric complexes are also included.
In the protein complex branch of the GO-CCO, most
protein complexes (729 of 1502) are direct subclasses of
‘protein complex’ itself. This ‘flat’ arrangement is not ideal
for the purposes of navigation and data summarization. GO
curators are working with the IntAct group [26] to improve
the sub-categorization of protein complexes. In cases where
a protein complex always contributes to a larger macromol-
ecular structure in a cell we provide a part_of relationship
between the protein complex and the larger component.
For example, ‘histone deacetylase complex’ is part of the nu-
cleoplasm in the GO. In cases where complexes are found
in multiple locations, or move between cell components,
the generic protein complex is merely part of ‘cell’.
Applications of the CC ontology
GO Annotation
The primary use of the GO-CCO is to annotate lo-
calization of gene products. There are currently 886238
annotations (both experimental and electronic) of gene
products from a variety of species. These annotations can
be interrogated with GO browsers such as AmiGO 2
[27,28] or QuickGO [29,30]. Annotation describes the
process of assigning GO terms to gene products. Annota-
tion can be carried out either automatically or manually.
Automated methods provide a fast and efficient way of
creating a large set of annotations. For automatic annota-
tion, curators have constructed various mapping files be-
tween external features and GO terms. GO annotations
are automatically applied to gene products via the map-
ping files. For example, InterPro entries are manually an-
notated with terms from the GO [31]. InterPro entryIPR019038 (DNA polymerase subunit Cdc27) contains a
mapping to GO:0005634 ‘nucleus’, and any protein that is
a member of this InterPro family will receive the annota-
tion GO:0005634. Similarly, UniProtKB entries are manu-
ally and electronically tagged with keywords [32] including
a cellular component category. A mapping file between
UniProtKB keywords and GO terms allows transitive elec-
tronic GO annotation of the UniProtKB entry.
Manual annotations are created by curators assessing
experimental evidence from published literature. Manual
annotations generally result in the use of more specific
GO terms. Curators use the experiments or analyses de-
scribed in a paper to infer the localization of a gene
product in a particular cellular compartment. For ex-
ample, a curator has annotated the human MPV17 mito-
chondrial membrane protein-like protein (MPV17L;
UniProtKB:Q2QL34) with the GO term GO:0005777
'peroxisome' using evidence from Iida et al., [33] who
demonstrate co-localization of MPV17L with a fluores-
cent peroxisomal marker.
Sequence-based analysis can also form the basis for an
annotation; GO-CCO annotations can be made based on
the presence of a key sequence or structural feature in the
gene product. Manual annotations can also be transferred
to similar gene products either computationally or when
orthology is indicated in the literature. Whether automatic
or manual, every annotation is attributed to a source (ei-
ther a literature reference, a computational analysis or an-
other database) and an evidence code is used to indicate
the type of evidence that supports the annotation [34].
Recently, the GO annotation model has been extended
to include contextual annotations. A GO annotation can
be further refined using ontology terms from within the
GO or other ontologies. For example, the PomBase an-
notation for the ‘cut8’ gene to ‘proteasome localization’
(a GO biological process term) is further refined by spe-
cifying that this localization takes place in the ‘nuclear
membrane’ (a GO-CCO term) (Figure 5).
Neuronal connectivity
Neuron connectivity maps provide a way to help under-
stand how the nervous system works. The FlyBase anatomy
Figure 5 Refining GO annotations using Gene Ontology CC terms. The PomBase annotation for the ‘cut8’ gene to ‘proteasome localization’
(a GO biological process term) is further refined by specifying that this localization takes place in the ‘nuclear membrane’ (a GO-CCO term). (Taken
from http://www.pombase.org/spombe/result/SPAC17C9.13c#go).
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tween neurons in the Drosophila nervous system [35] and
these relationships are used to deliver powerful queries
using the Virtual Fly Brain database [36]. These relation-
ships use the GO-CCO to precisely specify how the cells
are connected – for example, the has-pre-synaptic-ter-
minal-in relation is specified using the GO-CCO class
‘post-synaptic membrane’.
Image annotation
The Cell Image Library (CIL) is a database of cell im-
ages that is indexed using multiple ontologies [6]. The
GO-CCO is the ontology that is used to annotate any
subcellular structures highlighted in the image. The CIL
can be searched using GO terms, and the hierarchy of
the GO is incorporated into the query. For example,
searching for ‘cytoskeleton’ (GO:0005856) returns im-
ages annotated directly with ‘cytoskeleton’, as well as
cytoskeletal parts, such as ‘microtubule basal body’ e.g.
http://www.cellimagelibrary.org/images/38899.
Pathway and interaction databases
The GO-CCO has been used in a variety of pathway data-
bases such as IntAct and Reactome to specify the site in
which binding or a molecular event takes place.
IntAct [26], a member of the International Molecular
Exchange Consortium (IMEX), uses the GO-CCO to
capture molecular interaction data. The IntAct database
[37] can record the site of interaction by cross-
referencing interaction entries to GO-CCO terms. Over
8000 experimentally-defined IntAct interactions have
manually-assigned GO-CCO terms and users can search
on interaction cross-references to retrieve, for example,
all interactions that occur at the plasma membrane
(GO:0005886) or nucleus (GO:0005634).Because protein function and location are often tightly
linked, the manually curated and peer-reviewed pathway
database Reactome [38] cross-references GO-CCO terms
[39]. Reactome uses a subset of the GO-CCO to annotate
the subcellular locations of entities; entities include pro-
teins, nucleic acids, small molecules and subatomic parti-
cles, and can be a single molecule or a collection of
components such as a macromolecular complex. A GO-
CCO term is also a required attribute in the curation of a
Reactome event, a biochemical reaction with a defined in-
put (reactant) and output (product), such as the associ-
ation of two proteins to form a complex, or a catalytic
reaction.
Annotation of models
The EBI BioModels database [40,41] contains a number
of systems biology models represented in SBML (Sys-
tems Biology Markup Language) format. SBML provides
slots for indicating the compartment of a reaction,
resulting in the ability to search for models involving
particular cellular components, such as the ‘giant axon’.
Enhanced search of multiple resources
The GO-CCO can also be used to search a variety of data-
bases via the Neuinfo interface [16]. For example, searching
for data associated with “axoneme” (GO:0005930) [42]
returns several data types, including images of axonemes
and aging phenotypes associated with axonemes.
Phenotypes and disease
Although the GO-CCO, like the rest of the GO, focuses
on structures that are found mostly in ‘non-pathological’
contexts, the GO-CCO has applications in bioinformatics
analyses of phenotypes and diseases. The Mammalian
Phenotype (MP) ontology [43] contains terms for
Roncaglia et al. Journal of Biomedical Semantics 2013, 4:20 Page 9 of 11
http://www.jbiomedsem.com/content/4/1/20describing abnormalities observed in clinical or model or-
ganism experimental settings. Many MP terms such as
‘abnormal mitochondrion morphology’ have been trans-
lated to OWL expressions that reference GO-CCO terms
such as ‘mitochondrion’, allowing for cross-database
phenotype comparisons [44]. The Neurodegenerative Dis-
ease Phenotype Ontology (NDPO) [7], with its associated
Phenotype Knowledge Base (PKB), uses a model that in-
corporates descriptions for both human disease pheno-
types and those of animal models. Entities are drawn from
community ontologies (including the GO-CCO) made
available through the Neuroscience Information Frame-
work (NIF) and qualities are drawn from the Phenotype
and Trait Ontology (PATO). The resulting phenotype
statements describe structural alterations at the subcellu-
lar, cellular and gross anatomical levels.
Many diseases are the result of an abnormality within
a specific cell component. For example, the disease
class ‘ciliopathy’ encompasses a range of disorders such
as Bardet-Biedl syndrome and Alström syndrome char-
acterized or caused by an abnormality of the cilium or
its subcellular structures. Candidate genes for disorders
such as these can be found by scanning GO annota-
tions for gene products that are localized to, or play
some role in, the assembly of the relevant cellular
components.
Currently the GO-CCO has relationships to taxa of the
form ‘only in taxon’ or ‘never in taxon’ [45,46]. For ex-
ample, the CC ‘plastid’ has a never_in_taxon link to ‘Meta-
zoa’ and ‘Fungi’ supported by a particular publication (in
this case [47]). We intend to increase the coverage of GO
for certain kinds of unicellular organisms that are cur-
rently under-represented in GO. For example, trophozo-
ites such as Giardia have characteristic structures such as
a 'ventral disc', which can be further subdivided into other
parts such as microribbons and microtubular components.
These additions will be accompanied by the relevant taxon
constraints [45]. Our priority is to include new terms as
required for annotation. Other possible areas for extension
include dinoflagellates and algae.
Conclusions
For researchers to be best able to make use of the data
available to them, a single system for classification is essen-
tial. Prior to this work, the NIF’s SAO and the GO-CCO
provided alternative systems for classifying the same data,
potentially hindering cross-database analyses. The SAO
has now been incorporated into the GO-CCO, which was
expanded where necessary, with the result being a single
system of classification for subcellular entities across both
resources. The SAO was never intended, however, to repli-
cate the GO; rather, it was a means of specifying the rela-
tionships among structures encountered in microscopic
images. As such, it was a model for describing instances[3,48], rather than intending to serve as a reference ontol-
ogy. With the improvement in tools for working with com-
munity ontologies, in particular, tools to convert between
OBO format and OWL (http://oboformat.org) it no longer
made sense to maintain the two separately. Rather, the
SAO will be rebuilt as an annotation model that imports
the GO-CCO for cellular components.
The enhancements to the Cellular Component section of
the GO described in this paper will benefit researchers in
basic biology, biomedicine and systems biology who use
ontologies in their research. The amalgamation of the SAO
into the GO-CCO resulted in a single unified ontology
designed to serve the broad needs of GO annotators as
well as the specific needs of the neuroscience community.
Methods
Ontology Development
The SAO was originally developed using Protégé 3, and
the GO-CCO developed as part of GO using OBO-Edit
[49]. More recently the GO editors have been using a
hybrid approach, developing GO using a combination of
OBO-Edit, Protégé 4 and TermGenie [manuscript in
preparation]. In particular, a supplementary constraints
ontology called x-disjoints.owl is maintained in OWL
and used as part of the GO continuous integration sys-
tem [50] using OWL reasoners such as Elk [51]. This
ontology contains OWL axioms stating, for example,
that a nucleus and a cytoplasm can share no parts.
Amalgamation
In order to amalgamate the SAO into the GO-CCO, we
supplemented the manually maintained mappings be-
tween the SAO and the GO-CCO (which had become
stale since the SAO was first developed) with
automatically-generated mappings based on lexical
matching. These were all individually examined by GO
editors to determine their accuracy. If considered cor-
rect, they were added into the GO-CCO with a data-
base cross-reference to SAO.
For the remaining SAO terms for which no mapping
to the GO-CCO could be determined manually or auto-
matically, the GO editors evaluated each to determine if
it was appropriate to add to the GO. See the section
‘Amalgamation with SAO’ for more details.
Availability
The URL for the Gene Ontology (GO) is http://www.
geneontology.org/.
Gene Ontology files are publicly available for down-
load [52]. Detailed documentation on the Gene Ontol-
ogy can also be found online [53]. Researchers wishing
to annotate their experiments using GO terms may
refer to the GO’s annotation guidelines [54], and con-
tact the GO helpdesk [55].
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